[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:juvenile-myoclonic-epilepsy":3},{"name":4,"total":5,"trials":6,"biomarkers":22,"states":23},"Juvenile Myoclonic Epilepsy",2,[7,14],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT03400371","Biology of Juvenile Myoclonic Epilepsy",[],"RECRUITING","2026-08-03T03:46:33.830427Z","2026-05-13T02:55:06.123178Z",{"nct_id":15,"title":16,"phases":17,"status":19,"updated_at":20,"content_modified":21},"NCT07723963","A Phase 2\u002F3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy",[18],"Phase 2\u002FPhase 3","NOT_YET_RECRUITING","2026-08-03T01:02:42.162342Z","2026-07-24T01:27:14.923475Z",[],[]]